Generali Central Insurance is examining a health insurance product that would link premiums to the location where a policyholder receives treatment. MD and CEO KG Krishnamoorthy Rao's reasoning is hard to argue with: hospital costs vary significantly between cities, yet traditional health products charge broadly similar premiums regardless of where the customer lives or is treated. Under the proposal, a customer in Mumbai would pay more than one in Nagpur.

The Detail That Matters

The important part is not the geographic pricing. It is what happens when you cross a boundary. Under the structure Rao described, a customer from a lower-cost location who chooses treatment in a more expensive city would face a co-payment or additional contribution.

That reframes the product. It is not simply "pay less if you live somewhere cheaper" — it is a geographic network restriction with a financial penalty attached to stepping outside it. A Nagpur customer who wants a Mumbai hospital for a serious diagnosis would still be able to get there, but would pay part of the bill themselves.

Why Insurers Are Looking At This

Indian health insurance prices mainly on age, sum insured and, in some products, a broad zone rating. The actual cost drivers are hospital tariffs and utilisation, both of which vary enormously by city. Zone-based pricing already exists in crude form; this would be a finer-grained version of something the market has partly done for years.

There is a genuine fairness argument for it. Today, a customer in a low-cost city cross-subsidises one in a high-cost city, and the pricing signal to both is wrong. There is also a genuine fairness argument against it, which is why this will be interesting to watch through the IRDAI file-and-use process: geographic rating can shade into proxy discrimination, and a co-payment triggered by where you seek care rather than where you live is a novel mechanism in the Indian market.

What It Means for Customers

If this lands, the practical effect depends entirely on your treatment geography. Live and treat locally in a lower-cost city and your premium may fall. Have a standing relationship with a specialist in a metro, or a family pattern of travelling for serious treatment, and you could end up paying more in total than under a conventional policy — premium plus co-payment.

There is also a migration problem. People move. A product priced on treatment location raises the question of what happens at renewal when your pin code changes, and whether the change is to your advantage or not.

What It Means for Agents

This would turn a routine sale into a suitability question. Under a location-linked product, the material fact is not where the client lives but where they intend to be treated — and those are frequently different. A client with a Nagpur address and a long-standing cardiologist in Mumbai is a mis-selling risk waiting to happen.

If products like this reach the market, the questions to put on the fact-find are: which city would you actually go to for a serious diagnosis, do you have family medical relationships elsewhere, and do you travel for treatment today. Documenting the answers is what protects both the client and the agent.

Where Things Stand

Nothing has been filed and no launch date has been given — this is exploratory. Treat it as a signal of direction rather than a product you can buy. In the meantime, the useful action is to check whether your current policy already has zone-based pricing or a co-payment on treatment outside your zone. Many do, and most customers have never read that clause.

Generali Central is also weighing cyber-risk cover for bank depositors and identity theft protection, both at exploratory stage.

Source: The Hindu BusinessLine, 27 August 2026, reporting an interview with KG Krishnamoorthy Rao, MD and CEO, Generali Central Insurance.